Market Overview

Amgen Close to Buying Onyx Pharmaceuticals for $125/Share -NY TImes

Share:
Related ONXX
How to Prepare for the New Year
UPDATE: Stifel Terminates Coverage on Onyx Pharmaceuticals Following Acquisition by Amgen
Related AMGN
Carter Worth And Mike Khouw's Amgen Trade
What Pharmaceuticals Spend On Lobbying To Influence Trump

The New York Times is reporting that Amgen (NASDAQ: AMGN) is close to a deal to acquire Onyx Pharmaceuticals (NASDAQ: ONXX) for $125 per share. The deal could be announced on Monday, according to sources.

Onyx rejected an offer of $120 per share from Amgen. Onyx Pharmaceuticals closed Friday at $116.96.

Posted-In: NY TimesNews Rumors M&A

 

Related Articles (AMGN + ONXX)

View Comments and Join the Discussion!
Loading...
Loading...